全球 D-二聚体检测市场（按检测类型、技术、样本类型、最终用户和应用）预测 2025-2032

预计到 2032 年，D-二聚体检测市场将成长至 21.6 亿美元，复合年增长率为 6.98%。

主要市场统计数据
基准年2024年	12.6亿美元
预计2025年	13.5亿美元
预测年份：2032年	21.6亿美元
复合年增长率（%）	6.98%

重点介绍临床需求、技术进步和业务需求如何重塑医疗环境中的 D-二聚体诊断途径

D-二聚体检测为急诊、住院病房和门诊的临床决策提供信息，并已成为现代诊断途径的重要组成部分。 D-二聚体检测最初开发用于检测纤维蛋白降解产物，随着检测技术、快速照护现场平台和整合临床演算法的进步而不断发展。本简介概述了D-二聚体检测对医疗保健提供者和产业相关人员的临床效用、操作意义和策略相关性。

临床上，D-二聚体水平升高仍然是血栓事件（例如静脉血栓栓塞症）的敏感指标，并用于对患者进行进一步的影像学检查和抗凝血治疗。随着时间的推移，该检测的作用已扩展到包括筛检瀰漫性血管内凝血和对中风患者的辅助评估。从营运角度来看，实验室检测和快速就地检验的出现为护理路径创造了新的选择，更快、更分散的检测会影响工作量和临床结果。因此，医院实验室、诊断中心和门诊手术中心必须在分析效能与週转时间和工作流程整合之间取得平衡。

从策略角度来看，产业参与者和临床领导者正在应对不断变化的报销模式、不断发展的临床指南以及技术主导的差异化所带来的环境变化。检测化学和自动化领域的创新正在重新定义性能基准，而新兴的即时诊断解决方案则正在挑战传统的集中式检测模式。本节将组装。

临床演算法、技术创新和不断变化的报销动态如何重新定义 D-二聚体检测特异性诊断和患者管理

临床、技术和政策力量的融合正在改变D-二聚体检测的模式。在临床上，现代诊断演算法强调风险分层和选择性成像，越来越依赖高灵敏度的检测方法和一致的结果解释。这导致需要对实验室的检测通讯协定进行标准化，并在相关患者群体中检验检测性能。同时，检测化学的改进和自动化提高了分析精度，从而降低了检测阈值，并改善了血栓性疾病的阴性预测值。

在技​​术方面，快速即时诊断平台的普及正在实现分散式诊断，并促进床边和门诊的决策。这些设备缩短了获得诊断结果的时间，这可能会影响患者流量，尤其是在急诊科，因为及时治疗至关重要。此外，化学冷光免疫检测、萤光免疫分析和酵素结合免疫吸附分析的进步正在为中心实验室创造差异化的价值提案。

政策和报销格局也在发生变化，付款人和监管机构越来越重视临床效用和成本效益的证据。这种转变有利于能够显着降低不必要成像和下游成本的整合诊断解决方案。因此，製造商和临床实验室正在投资真实世界证据生成和合作研究，以检验诊断途径。这些临床、技术和政策的转变正在重新定义竞争动态，并为兼具分析稳健性和营运敏捷性的解决方案创造机会。

评估 2025 年美国关税变化对营运和采购的影响，并思考它们将如何推动诊断供应链的弹性和筹资策略

2025年美国关税调整和贸易政策转变的累积效应正在重塑与D-二聚体检测相关的诊断设备和耗材的筹资策略。试剂、仪器组件和完整诊断平台的进口成本不断上升，迫使实验室和医疗系统重新评估其采购方式、物流计划和供应商多元化措施。对于依赖国际供应链试剂组和专用检测组件的机构来说，这些商业性压力尤其突出，导致其更加重视库存管理和合约重新谈判。

为了应对与关税相关的成本负担，许多相关人员正在寻求营运调整，例如与优先供应商整合采购量、探索国内製造伙伴关係关係，以及优先考虑检测项目以最大程度地降低耗材的复杂性。临床实验室正在更严格地评估总拥有成本、权衡仪器摊销、试剂有效期以及与每次检测成本相关的服务支援。这一趋势也促使供应商推出捆绑解决方案和灵活的商业模式，以减轻前期投资负担，例如试剂租赁协议和基于绩效的合约。

对临床交付的净影响是更加重视弹性和供应链透明度。卫生系统正在实施双重采购策略，并扩展内部检验能力，以降低服务中断的风险。同时，供应商正在加快本地化进程，并探索不易受关税波动影响的替代材料和检测方法。总而言之，这些应对措施正在推动整个诊断生态系统在成本、品质和业务连续性方面实现务实的再平衡。

深入的细分洞察，展示产品类型、检测技术、样本基质、临床环境和应用如何独特地塑造采用和产品策略

细分市场动态揭示了按检测类型、技术、样本类型、最终用户和应用分類的差异化价值驱动因素，每种因素都会影响临床应用和商业性定位。就检测类型而言，实验室检测和即时诊断解决方案之间的差异性造就了不同的用例。就技术而言，化学化学冷光免疫检测因其自动化的工作流程和更高的灵敏度而常用于高容量实验室；酵素结合免疫吸附检测法为专业检测和研究环境提供了灵活性；萤光免疫分析支持紧凑、灵敏的系统，适用于近患者和中心实验室部署；而乳胶凝集测试在简便性和成本控制是优先考虑因素时仍然具有实用价值。

检体类型的考虑也会影响采购和工作流程的选择。血浆样本通常用于中心实验室工作流程，因为它们与自动化分析仪相容且可进行标准化处理。在凝血控制和样本稳定性至关重要的环境中，通常会选择血清；而在即时检测（无需离心）以简化临床决策的照护现场检测中，全血至关重要。门诊手术中心需要快速可靠的检测方法，以支持当日手术并最大限度地减少取消率。诊断实验室需要能够整合到现有自动化卡车中的高通量、检验的平台。医院需要结合集中式和近患者功能，以支援急诊、住院和手术全期工作流程。例如，用于弥散性血管内凝血的检测需要强大的灵敏度和动态范围以捕捉凝血异常；用于中风的检测需要快速的周转时间并与急性护理演算法相容；而静脉血栓栓塞症的评估则受益于高阴性预测值和标准化的解释标准。这种细分观点将为产品设计、打入市场策略和临床检验重点提供信息，使寻求提供适合临床和诊断目的的产品的相关人员受益。

影响美洲、欧洲、中东和非洲以及亚太地区招聘、法规和筹资策略的区域动态和市场驱动因素

区域动态对于塑造关键地区 D-二聚体侦测解决方案的需求模式、监管预期和竞争格局至关重要。美洲地区的特点是临床应用先进，对急诊护理中即时诊断部署的重视程度日益加深，且支付方环境对成本效益和临床影响证据的要求也日益严格。该地区的实验室和医院通常寻求将检测性能与营运效率相结合的整合解决方案，而製造商则优先考虑符合国家监管标准，以促进市场准入。

在欧洲、中东和非洲，分散的医疗保健系统和监管协调工作造成了复杂的市场环境。在一些欧洲市场，集中采购和强大的实验室基础设施有利于高通量检测，而该地区的其他市场则由于准入限製而强调分散式检查。不同地区的监管趋势差异很大，这会影响产品的上市时间表，并需要製定量身定制的临床检验策略。在亚太地区的许多地区，价格敏感度和物流因素会影响照护现场的便利性与集中分析的严谨性之间的平衡。

亚太地区的特点是采用曲线快速，医疗保健基础设施投入巨大，以及都市区三级医疗中心和乡村诊所的混合分布。改善急诊就诊和减少诊断延误的需求推动了对高通量实验室平台和价格实惠的快速检测的强劲需求。在一些国家，本地製造和监管措施正在提升国内产能，并加快区域特定解决方案的上市时间。在整个地区，製造商、临床医生和采购组织之间的合作对于使产品功能与临床工作流程和报销现实保持一致至关重要，从而促进产品的合理采用和永续利用。

竞争格局分析重点介绍了现有企业、专业开发商和照护现场创新者如何透过技术、伙伴关係和证据产生来实现差异化

D-二聚体检测市场由现有诊断製造商、专业检测试剂开发商和新参与企业即时诊断领域的企业之间的竞争态势所塑造。现有企业凭藉其在临床实验室的装置量、广泛的试剂组合以及支援大批量集中检测的全球服务网络，保持自身优势。这些现有企业利用其在实验室自动化和资讯系统整合方面的能力作为竞争壁垒，同时投资于检测性能的渐进式改进，以保持在医院系统和参考实验室中的相关性。

同时，专业检测试剂开发商和利基市场供应商正在推动差异化化学方法和紧凑型平台，以满足尚未满足的临床需求，尤其是快速分流和分散式护理。这些供应商标榜其快速获得结果、易于使用和最小化样本处理。新兴企业和POC（即临床医生诊断）参与企业正透过专注于以临床医生为中心的设计、简化的使用者介面以及与电子健康记录和临床决策支援系统的直接连接，挑战传统模式。策略伙伴关係、共同开发契约和通路多角化是整个竞争格局中常用的策略，旨在加速市场渗透并克服监管和报销障碍。

对于所有类型的公司而言，透过临床试验、真实世界检验和健康经济评估来获取证据是脱颖而出的关键。能够展现出持续的分析表现、工作流程优势以及显着降低下游影像和住院费用的公司，将更有能力确保处方投放并获得医疗服务提供者的认可。随着生态系统的发展，製造商和医疗保健机构之间合作试行新的部署模式，将持续影响哪些公司能获得长期价值。

诊断製造商和医疗保健提供者可采取的策略重点，以最大限度地提高 D-二聚体检测的临床应用、供应弹性和商业性影响

行业领导者应优先考虑一系列可行的策略，将商业性可行性与临床影响和营运现实相结合。首先，投资有针对性的临床证据计划，量化特定D-二聚体检测法对病患路径、影像学利用率和住院时长指标的影响。此类研究应与最终用户合作，根据具体情况进行设计，以确保相关性和可靠性。其次，开发灵活的商业倡议，降低采用的资本障碍，例如试剂租赁协议、与结果挂钩的定价以及基于订阅的数据分析和支援服务。此类模式将提高可近性，同时将供应商奖励与实验室绩效和运作结合。

第三，透过多元化製造地和製定关键试剂和零件的紧急采购计划，增强供应链的弹性。与机构买家就前置作业时间和风险缓解策略进行透明沟通，可以建立信任并减少采购摩擦。第四，透过与实验室资讯系统和电子健康记录的互通性，优先考虑与临床工作流程的无缝集成，并提供培训和支援以加速采用。医院重视整合实验室解决方案和服务支持，诊断实验室优先考虑吞吐量和自动化相容性，门诊手术中心寻求快速、可靠的检测方法，以最大限度地减少手术延迟。

最后，制定注重临床效用和健康经济效益的监管和报销策略。儘早与付款方和卫生技术评估机构沟通，并提案，可以缩短商业化时间并提高应用率。透过执行这些优先事项，行业领导者可以将技术优势转化为永续的市场地位和患者照护的显着改善。

严格的混合方法研究途径结合了前线相关人员访谈、临床文献回顾和交叉检验的分析技术，产生了可行的诊断见解

本研究综合运用一手资料和二手资料，以确保研究的严谨性和有效性。一手资料包括与实验室主任、临床病理学家、急诊科医生、采购专业人员和产品经理的相关人员访谈，并辅以实地考察，以了解工作流程的限制和应用障碍。这些直接的接触为实际检测效能、预期交付时间和采购决策标准提供了定性见解。二级资讯来源包括同行评审的临床文献、监管备案文件、设备说明书和公开的临床指南，这些指南为检测效用和推荐的诊断演算法提供了资讯。

资料合成涉及定性见解与记录证据的交叉检验，以确定共识主题并标记需要进一步调查的差异领域。分析方法包括比较技术评估、最终用户与临床工作流程的映射，以及基于情境的评估不同资费条件下的供应链影响。调查方法的品管包括方法论三角检验、反覆的相关人员检验会议以及内部同行评审，以确保研究结果的稳健性和可验证性。这种方法的挑战包括难以获取专有商业数据，以及监管和报销格局的动态性，这些因素在原始数据收集后可能会发生变化。

为了缓解这些局限性，本研究纳入了敏感性检验，并记录了其解释性结论背后的假设。在可能的情况下，我们制定了应对短期市场波动的建议，并强调相关人员可控范围内的营运措施。本调查方法提供了可操作的、基于证据的见解，可供医疗保健领导者和商业团队应用于其D-二聚体检测策略决策。

最终整合凸显了临床价值、营运弹性和可互通解决方案如何决定 D-二聚体诊断生态系统的长期成功

累积分析强调，D-二聚体检测处于临床需求、技术创新和营运决策的策略交汇点。高灵敏度检测和快速即时诊断解决方案相辅相成，而非相互排斥，从而能够实现将分析性能与医疗环境要求相匹配的分级诊断方法。随着支付方和医疗机构强调基于价值的医疗服务和高效的资源利用，能够证明D-二聚体检测如何减少不必要的影像学检查并简化患者流程的证据，对于塑造应用模式至关重要。

从营运角度来看，供应链的弹性和采购的灵活性对于持续提升侦测能力至关重要。积极管理采购管道并与供应商签订基于绩效合约的实验室和医疗系统，在面临关税和物流中断的情况下，将更有能力保持业务连续性。从竞争角度来看，将强大的分析能力与以临床医生为中心的易用性和可互通数据架构相结合的公司，将更有能力获得更强大的组织伙伴关係和应用势头。

总而言之，相关人员不应将D-二聚体检测仅视为单一的检测，而应将其视为更广泛诊断路径中的一个环节，该路径需要协调一致的临床、营运和商业策略。成功的组织将是那些能够展示真实临床价值、切实管理供应和成本压力，并提供无缝整合到异质医疗环境中的解决方案的组织。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 开发照护现场D-二聚体检测方法，用于紧急情况下的快速分类
• 利用奈米技术的高灵敏度 D-二聚体试剂的出现提高了 VTE 诊断的阴性预测值
• 透过远距血栓症监测远端医疗平台，增加直接面向消费者的 D-二聚体家庭采样套件的销售
• 采用人工智慧演算法，结合 D-二聚体水平和患者病历，对 COVID-19 患者进行个别化风险分层
• 结合 D-二聚体和纤维蛋白原降解产物进行综合凝血分析的多重检测的需求日益增长
• 扩大手术中 D-二聚体检测，以便早期发现术后血栓併发症
• 将 D-二聚体检测整合到急诊室的床边超音波导引通讯协定中，用于评估肺动脉栓塞
• 开发冻干 D-二聚体试剂以简化资源有限地区的储存和分发

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. D-二聚体检测市场（依检测类型）

• 基于实验室
• 照护现场

9. D-二聚体检测市场（按技术）

• 化学冷光免疫检测
• 酵素结合免疫吸附试验
• 萤光免疫分析法
• 乳胶凝集测试

第 10 章：D-二聚体检测市场（依样本类型）

• 电浆
• 血清
• 全血

第 11 章 D-二聚体检测市场（按最终用户）

• 门诊手术中心
• 诊断实验室
• 医院

第12章 D-二聚体检测市场（依应用）

• 瀰漫性血管内凝血
• 中风
• 静脉血栓栓塞症

第 13 章：D-二聚体检测市场（按地区）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第14章 D-二聚体检测市场（依类别）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第 15 章。按国家/地区分類的 D-二聚体检测市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章竞争格局

• 2024年市占率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Siemens Healthineers AG
  • Roche Diagnostics GmbH
  • Sysmex Corporation
  • Abbott Laboratories
  • bioMerieux SA
  • Beckman Coulter, Inc.
  • Thermo Fisher Scientific Inc.
  • Instrumentation Laboratory Company
  • DiaSorin SpA
  • Ortho Clinical Diagnostics Inc.

The D-dimer Testing Market is projected to grow by USD 2.16 billion at a CAGR of 6.98% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 1.26 billion
Estimated Year [2025]	USD 1.35 billion
Forecast Year [2032]	USD 2.16 billion
CAGR (%)	6.98%

A focused introduction explaining how clinical necessity, technological advances, and operational demands are reshaping D-dimer diagnostic pathways in care settings

D-dimer testing has become an essential element of modern diagnostic pathways, informing clinical decision-making across emergency departments, inpatient wards, and ambulatory settings. Initially developed as a laboratory assay to detect fibrin degradation products, D-dimer testing has evolved in parallel with advances in assay technology, rapid point-of-care platforms, and integrated clinical algorithms. This introduction outlines the clinical utility, operational implications, and strategic relevance of D-dimer diagnostics for healthcare providers and industry stakeholders.

Clinically, elevated D-dimer levels remain a sensitive indicator for thrombotic events such as venous thromboembolism and are used to triage patients for further imaging or anticoagulation therapy. Over time, the role of the test has broadened to include screening for disseminated intravascular coagulation and adjunctive evaluation of stroke patients. From an operational perspective, the availability of both laboratory-based assays and rapid point-of-care options has created new choices for care pathways where speed and decentralization of testing influence throughput and clinical outcomes. As a result, hospital laboratories, diagnostic centers, and ambulatory surgical units must balance analytical performance with turnaround time and workflow integration.

Strategically, industry participants and clinical leaders are navigating an environment shaped by changing reimbursement paradigms, evolving clinical guidelines, and technology-driven differentiation. Innovations in assay chemistries and automation are redefining performance benchmarks, while emerging point-of-care solutions are challenging traditional centralized testing models. This section frames the subsequent deeper analysis by highlighting the clinical drivers, technological enablers, and institutional considerations that make D-dimer testing a focal point for diagnostic strategy and investment.

How clinical algorithms, technological innovation, and evolving reimbursement dynamics are collectively redefining diagnostics and patient management with D-dimer testing

The landscape of D-dimer testing is experiencing transformative shifts driven by converging clinical, technological, and policy forces. Clinically, updated diagnostic algorithms emphasize risk stratification and selective imaging, increasing reliance on high-sensitivity assays and consistent result interpretation. This creates pressure to standardize testing protocols across institutions and to validate assay performance within relevant patient cohorts. Simultaneously, improvements in assay chemistries and automation have elevated analytical precision, enabling lower detection thresholds and improving negative predictive value for thrombotic conditions.

On the technology front, the proliferation of rapid point-of-care platforms is enabling diagnostic decentralization and facilitating decision-making at the bedside or in ambulatory settings. These devices reduce time-to-result and can influence patient flow, particularly in emergency departments where timely disposition is critical. Moreover, advances in chemiluminescence immunoassays, fluorescence immunoassays, and enzyme-linked immunosorbent approaches are generating differentiated value propositions for central laboratories, whereas latex agglutination methods continue to offer cost-effective alternatives in specific contexts.

Policy and reimbursement landscapes are also shifting, with payers and regulators increasingly focusing on evidence of clinical utility and cost-effectiveness. These changes favor integrated diagnostic solutions that demonstrably reduce unnecessary imaging and downstream costs. As a result, manufacturers and clinical labs are investing in real-world evidence generation and collaborative studies to validate diagnostic pathways. Together, these clinical, technological, and policy shifts are redefining competitive dynamics and creating opportunities for solutions that blend analytical robustness with operational agility.

Assessing the operational and procurement consequences of US tariff shifts in 2025 and how they are driving supply chain resilience and sourcing strategies for diagnostics

The cumulative effect of tariff adjustments and trade policy shifts in the United States during 2025 is reshaping procurement strategies for diagnostic equipment and consumables connected to D-dimer testing. Heightened import costs for reagents, instrumentation components, and finished diagnostic platforms have prompted laboratories and health systems to reassess sourcing approaches, logistics planning, and supplier diversification efforts. These commercial pressures are particularly acute for facilities that rely on international supply chains for reagent kits and specialized assay components, leading to an increased focus on inventory management and contract renegotiation.

In response to tariff-related cost burdens, many stakeholders are pursuing operational adaptations such as consolidating procurement volumes with preferred suppliers, exploring domestic manufacturing partnerships, and prioritizing assays that minimize consumable complexity. Clinical laboratories are evaluating the total cost of ownership more rigorously, weighing instrument amortization, reagent shelf-life, and service support against unit test costs. These dynamics have also encouraged vendors to introduce bundled solutions and flexible commercial models, including reagent rental agreements and performance-based contracts that mitigate up-front capital exposure.

The net effect on clinical delivery is a heightened emphasis on resilience and supply-chain transparency. Health systems are instituting dual-sourcing strategies and expanding in-house validation capabilities to reduce service disruption risk. At the same time, vendors are accelerating localization efforts and exploring alternative materials or assay formats that are less vulnerable to tariff volatility. Collectively, these responses are guiding a pragmatic rebalancing of cost, quality, and operational continuity across the diagnostic ecosystem.

Deep segmentation insights showing how test type, assay technologies, sample matrices, clinical settings, and applications uniquely shape adoption and product strategy

Segment-level dynamics reveal differentiated value drivers across test type, technology, sample type, end user, and application, each of which shapes clinical adoption and commercial positioning. In terms of test type, the dichotomy between laboratory-based assays and point-of-care solutions creates distinct use case pathways: centralized laboratory platforms prioritize throughput, analytic precision, and integration with laboratory information systems, while point-of-care options emphasize rapid turnaround, portability, and direct clinician-facing results. Concerning technology, chemiluminescence immunoassays frequently serve high-volume laboratories with automated workflows and enhanced sensitivity; enzyme-linked immunosorbent assays offer flexibility for specialized testing and research contexts; fluorescence immunoassays support compact, sensitive systems suitable for both near-patient and central lab deployment; and latex agglutination methods remain relevant where simplicity and cost containment are prioritized.

Sample type considerations also drive procurement and workflow choices. Plasma samples are commonly used in centralized lab workflows for their compatibility with automated analyzers and standardized processing; serum is selected in settings where coagulation control and sample stability matter; and whole blood is pivotal for point-of-care environments where immediate testing without centrifugation streamlines clinical decision-making. End user segmentation sheds light on setting-specific requirements: ambulatory surgical centers demand rapid, reliable assays that support same-day procedures and minimize cancellations; diagnostic laboratories require high-throughput, validated platforms that integrate into existing automation tracks; and hospitals need a mixture of centralized and near-patient capabilities to support emergency, inpatient, and perioperative workflows. Finally, application-driven insights emphasize clinical priorities: tests used for disseminated intravascular coagulation require robust sensitivity and dynamic range to capture coagulation abnormalities; stroke applications necessitate fast turnaround and compatibility with acute care algorithms; and venous thromboembolism evaluation benefits from high negative predictive value and standardized interpretive criteria. Taken together, these segmentation perspectives inform product design, go-to-market strategies, and clinical validation priorities for stakeholders seeking to align offerings with distinct care settings and diagnostic objectives.

Regional dynamics and market drivers across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence adoption, regulation, and procurement strategies

Regional dynamics are pivotal in shaping demand patterns, regulatory expectations, and the competitive landscape for D-dimer testing solutions across major geographies. The Americas region is characterized by advanced clinical adoption, growing emphasis on point-of-care deployment in emergency medicine, and payer environments that increasingly require evidence of cost-effectiveness and clinical impact. Laboratories and hospitals in this region often pursue integrated solutions that link assay performance with operational efficiency, and manufacturers prioritize regulatory alignment with national standards to facilitate market access.

In Europe, Middle East & Africa, fragmentation in healthcare systems and regulatory harmonization efforts create a complex market environment. In some European markets, centralized procurement and strong laboratory infrastructures favor high-throughput laboratory assays, while other markets within the region place greater emphasis on decentralized testing due to access constraints. Regulatory pathways vary widely across the region, which affects timelines for product introduction and necessitates tailored clinical validation strategies. In many parts of the region, price sensitivity and logistics considerations influence the balance between point-of-care convenience and centralized analytical rigor.

The Asia-Pacific region is notable for rapid adoption curves, significant investments in healthcare infrastructure, and a heterogeneous mix of urban tertiary centers and rural clinics. Demand for both high-throughput laboratory platforms and affordable rapid tests is strong, driven by the need to improve acute care triage and reduce diagnostic delays. Local manufacturing and regulatory initiatives in several countries are fostering domestic production capabilities and shortening time-to-market for region-specific solutions. Across all regions, collaboration between manufacturers, clinicians, and procurement bodies is instrumental in aligning product capabilities with clinical workflows and reimbursement realities, thereby accelerating appropriate adoption and sustainable utilization.

Competitive landscape analysis emphasizing how incumbents, specialized developers, and point-of-care innovators are differentiating through technology, partnerships, and evidence generation

Competitive dynamics among established diagnostic companies, specialized assay developers, and emerging point-of-care entrants are shaping the D-dimer testing marketplace. Legacy manufacturers maintain strength through installed bases in clinical laboratories, broad reagent portfolios, and global service networks that support high-volume central testing. These incumbents leverage integration capabilities with laboratory automation and information systems as a competitive moat, while investing in incremental assay performance improvements to preserve relevance in hospital systems and reference laboratories.

At the same time, specialized assay developers and niche vendors are advancing differentiated chemistries and compact platforms that address unmet clinical needs, particularly in rapid triage and decentralized care. These players often emphasize speed-to-result, ease-of-use, and minimal sample processing as core selling points. Startups and point-of-care entrants are challenging traditional models by focusing on clinician-centric design, simplified user interfaces, and connectivity features that feed directly into electronic medical records and clinical decision support systems. Strategic partnerships, co-development agreements, and channel diversification are common tactics deployed across the competitive landscape to accelerate market penetration and to overcome regulatory and reimbursement hurdles.

Across all company types, evidence generation through clinical studies, real-world validations, and health economic assessments is a central differentiator. Firms that can demonstrate consistent analytical performance, workflow benefits, and measurable reductions in downstream imaging or hospitalization are better positioned to secure formulary placements and institutional buy-in. As the ecosystem evolves, collaboration between manufacturers and healthcare institutions on piloting new deployment models will continue to influence which companies capture long-term value.

Actionable strategic priorities for diagnostic manufacturers and healthcare providers to maximize clinical adoption, supply resilience, and commercial impact for D-dimer testing

Industry leaders should prioritize a set of actionable strategies that align commercial execution with clinical impact and operational realities. First, invest in targeted clinical evidence initiatives that quantify how specific D-dimer assays influence patient pathways, imaging utilization, and length-of-stay metrics. These studies should be context-specific and designed in collaboration with end users to ensure relevance and credibility. Second, develop flexible commercial models that reduce capital barriers for adoption, such as reagent rental agreements, outcome-linked pricing, or subscription-based access to data analytics and support services. Such models increase accessibility while aligning supplier incentives with laboratory performance and uptime.

Third, strengthen supply chain resilience by diversifying manufacturing footprints and creating contingency sourcing plans for critical reagents and components. Transparent communication with institutional buyers about lead times and risk mitigation measures will build trust and reduce procurement friction. Fourth, prioritize seamless integration with clinical workflows through interoperability with laboratory information systems and electronic health records, as well as by providing training and support that accelerates adoption. Fifth, tailor go-to-market approaches by end-user segment: hospitals will value integrated laboratory solutions and service support; diagnostic laboratories will prioritize throughput and automation compatibility; ambulatory surgical centers will seek rapid, reliable assays that minimize procedural delays.

Finally, pursue regulatory and reimbursement strategies that emphasize clinical utility and health economic benefit. Engaging early with payers and health technology assessment bodies to present robust value propositions can shorten commercialization timelines and improve uptake. By executing on these priorities, industry leaders can translate technological advantages into sustainable market positions and demonstrable improvements in patient care.

A rigorous mixed-methods research approach combining frontline stakeholder interviews, clinical literature review, and cross-validated analytical techniques to produce actionable diagnostics insights

This research synthesizes evidence from a combination of primary and secondary sources to ensure rigor and relevance. Primary inputs include stakeholder interviews with laboratory directors, clinical pathologists, emergency medicine physicians, procurement professionals, and product managers, supplemented by site visit observations to understand workflow constraints and adoption barriers. These direct engagements provide qualitative insights into real-world assay performance, turnaround time expectations, and procurement decision criteria. Secondary sources encompass peer-reviewed clinical literature, regulatory filings, device instructions for use, and publicly available clinical guidelines that inform assay utility and recommended diagnostic algorithms.

Data synthesis involved cross-validation between qualitative insights and documented evidence to identify consensus themes and to flag areas of divergence requiring further investigation. Analytical methods included comparative technology assessment, end-user mapping to clinical workflows, and scenario-based evaluation of supply-chain impacts under varying tariff conditions. Quality control measures comprised methodological triangulation, repeated stakeholder validation sessions, and internal peer review to ensure findings are robust and defensible. Limitations of the approach include variable availability of proprietary commercial data and the dynamic nature of regulatory and reimbursement landscapes, which can evolve after primary data collection.

To mitigate these limitations, the research incorporates sensitivity checks and documents assumptions underlying interpretive conclusions. Where possible, recommendations are framed to be resilient to short-term market fluctuations and to emphasize operational levers that stakeholders can control. This methodology enables practical, evidence-based insights that healthcare leaders and commercial teams can apply to decision-making around D-dimer testing strategies.

A conclusive synthesis highlighting how clinical value, operational resilience, and interoperable solutions determine long-term success in the D-dimer diagnostics ecosystem

The cumulative analysis underscores that D-dimer testing occupies a strategic intersection of clinical necessity, technological innovation, and operational decision-making. High-sensitivity assays and rapid point-of-care solutions are not mutually exclusive but complementary, enabling a tiered diagnostic approach that aligns analytical performance with care setting requirements. As payers and providers emphasize value-based care and efficient resource utilization, evidence demonstrating how D-dimer testing reduces unnecessary imaging and streamlines patient flow will be decisive in shaping adoption patterns.

Operationally, supply-chain resilience and procurement flexibility are critical enablers of uninterrupted testing capacity. Laboratories and health systems that proactively manage sourcing channels and that engage with vendors on performance-based contracting will be better positioned to maintain continuity in the face of tariff or logistic disruptions. From a competitive standpoint, companies that marry robust analytical performance with clinician-focused usability and interoperable data architectures will secure stronger institutional partnerships and adoption momentum.

In conclusion, stakeholders should view D-dimer testing not merely as a single assay but as an element within broader diagnostic pathways that require coordinated clinical, operational, and commercial strategies. The organizations that succeed will be those that can demonstrate real-world clinical value, manage supply and cost pressures pragmatically, and deliver solutions that integrate seamlessly into heterogeneous care settings.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Development of point-of-care D-dimer assays integrating smartphone connectivity for rapid triage in emergency settings
• 5.2. Emergence of high-sensitivity D-dimer reagents utilizing nanotechnology for improved negative predictive value in VTE diagnosis
• 5.3. Growth of direct-to-consumer D-dimer home sampling kits supported by telehealth platforms for remote thrombosis monitoring
• 5.4. Adoption of AI-driven algorithms combining D-dimer levels with patient history for personalized risk stratification in COVID-19 patients
• 5.5. Rising demand for multiplex assays combining D-dimer with fibrinogen degradation products for comprehensive coagulation profiling
• 5.6. Expansion of D-dimer testing in surgical settings for early detection of postoperative thrombotic complications
• 5.7. Integration of D-dimer testing into point-of-care ultrasound-guided protocols for emergency department pulmonary embolism assessment
• 5.8. Development of lyophilized D-dimer reagents to simplify storage and distribution in resource-limited regions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. D-dimer Testing Market, by Test Type

• 8.1. Laboratory Based
• 8.2. Point Of Care

9. D-dimer Testing Market, by Technology

• 9.1. Chemiluminescence Immunoassay
• 9.2. Enzyme Linked Immunosorbent Assay
• 9.3. Fluorescence Immunoassay
• 9.4. Latex Agglutination

10. D-dimer Testing Market, by Sample Type

• 10.1. Plasma
• 10.2. Serum
• 10.3. Whole Blood

11. D-dimer Testing Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Diagnostic Laboratories
• 11.3. Hospitals

12. D-dimer Testing Market, by Application

• 12.1. Disseminated Intravascular Coagulation
• 12.2. Stroke
• 12.3. Venous Thromboembolism

13. D-dimer Testing Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. D-dimer Testing Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. D-dimer Testing Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Siemens Healthineers AG
  • 16.3.2. Roche Diagnostics GmbH
  • 16.3.3. Sysmex Corporation
  • 16.3.4. Abbott Laboratories
  • 16.3.5. bioMerieux SA
  • 16.3.6. Beckman Coulter, Inc.
  • 16.3.7. Thermo Fisher Scientific Inc.
  • 16.3.8. Instrumentation Laboratory Company
  • 16.3.9. DiaSorin S.p.A
  • 16.3.10. Ortho Clinical Diagnostics Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL D-DIMER TESTING MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL D-DIMER TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL D-DIMER TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL D-DIMER TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS D-DIMER TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL D-DIMER TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. D-DIMER TESTING MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. D-DIMER TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. D-DIMER TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL D-DIMER TESTING MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL D-DIMER TESTING MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL D-DIMER TESTING MARKET SIZE, BY LABORATORY BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL D-DIMER TESTING MARKET SIZE, BY LABORATORY BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL D-DIMER TESTING MARKET SIZE, BY LABORATORY BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL D-DIMER TESTING MARKET SIZE, BY LABORATORY BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL D-DIMER TESTING MARKET SIZE, BY LABORATORY BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL D-DIMER TESTING MARKET SIZE, BY LABORATORY BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL D-DIMER TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL D-DIMER TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL D-DIMER TESTING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL D-DIMER TESTING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL D-DIMER TESTING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL D-DIMER TESTING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL D-DIMER TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL D-DIMER TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL D-DIMER TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL D-DIMER TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL D-DIMER TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL D-DIMER TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL D-DIMER TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL D-DIMER TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL D-DIMER TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL D-DIMER TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL D-DIMER TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL D-DIMER TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL D-DIMER TESTING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL D-DIMER TESTING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL D-DIMER TESTING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL D-DIMER TESTING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL D-DIMER TESTING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL D-DIMER TESTING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL D-DIMER TESTING MARKET SIZE, BY LATEX AGGLUTINATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL D-DIMER TESTING MARKET SIZE, BY LATEX AGGLUTINATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL D-DIMER TESTING MARKET SIZE, BY LATEX AGGLUTINATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL D-DIMER TESTING MARKET SIZE, BY LATEX AGGLUTINATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL D-DIMER TESTING MARKET SIZE, BY LATEX AGGLUTINATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL D-DIMER TESTING MARKET SIZE, BY LATEX AGGLUTINATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL D-DIMER TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL D-DIMER TESTING MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL D-DIMER TESTING MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL D-DIMER TESTING MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL D-DIMER TESTING MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL D-DIMER TESTING MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL D-DIMER TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL D-DIMER TESTING MARKET SIZE, BY SERUM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL D-DIMER TESTING MARKET SIZE, BY SERUM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL D-DIMER TESTING MARKET SIZE, BY SERUM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL D-DIMER TESTING MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL D-DIMER TESTING MARKET SIZE, BY SERUM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL D-DIMER TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL D-DIMER TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL D-DIMER TESTING MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL D-DIMER TESTING MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL D-DIMER TESTING MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL D-DIMER TESTING MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL D-DIMER TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL D-DIMER TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL D-DIMER TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL D-DIMER TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL D-DIMER TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL D-DIMER TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL D-DIMER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL D-DIMER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL D-DIMER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL D-DIMER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL D-DIMER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL D-DIMER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL D-DIMER TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL D-DIMER TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL D-DIMER TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL D-DIMER TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL D-DIMER TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL D-DIMER TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL D-DIMER TESTING MARKET SIZE, BY DISSEMINATED INTRAVASCULAR COAGULATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL D-DIMER TESTING MARKET SIZE, BY DISSEMINATED INTRAVASCULAR COAGULATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL D-DIMER TESTING MARKET SIZE, BY DISSEMINATED INTRAVASCULAR COAGULATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL D-DIMER TESTING MARKET SIZE, BY DISSEMINATED INTRAVASCULAR COAGULATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL D-DIMER TESTING MARKET SIZE, BY DISSEMINATED INTRAVASCULAR COAGULATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL D-DIMER TESTING MARKET SIZE, BY DISSEMINATED INTRAVASCULAR COAGULATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL D-DIMER TESTING MARKET SIZE, BY STROKE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL D-DIMER TESTING MARKET SIZE, BY STROKE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL D-DIMER TESTING MARKET SIZE, BY STROKE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL D-DIMER TESTING MARKET SIZE, BY STROKE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL D-DIMER TESTING MARKET SIZE, BY STROKE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL D-DIMER TESTING MARKET SIZE, BY STROKE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL D-DIMER TESTING MARKET SIZE, BY VENOUS THROMBOEMBOLISM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL D-DIMER TESTING MARKET SIZE, BY VENOUS THROMBOEMBOLISM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL D-DIMER TESTING MARKET SIZE, BY VENOUS THROMBOEMBOLISM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL D-DIMER TESTING MARKET SIZE, BY VENOUS THROMBOEMBOLISM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL D-DIMER TESTING MARKET SIZE, BY VENOUS THROMBOEMBOLISM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL D-DIMER TESTING MARKET SIZE, BY VENOUS THROMBOEMBOLISM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL D-DIMER TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL D-DIMER TESTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 107. AMERICAS D-DIMER TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 108. AMERICAS D-DIMER TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 109. AMERICAS D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 110. AMERICAS D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 111. AMERICAS D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 112. AMERICAS D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 113. AMERICAS D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 114. AMERICAS D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 115. AMERICAS D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 116. AMERICAS D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 117. AMERICAS D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 118. AMERICAS D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 119. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 122. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 123. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 124. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 125. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 126. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 127. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 128. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 129. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 130. NORTH AMERICA D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 131. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 134. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 135. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 136. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 137. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 138. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 139. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 140. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 141. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 142. LATIN AMERICA D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 143. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 144. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 155. EUROPE D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 156. EUROPE D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 157. EUROPE D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 158. EUROPE D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 159. EUROPE D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 160. EUROPE D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 161. EUROPE D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 162. EUROPE D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 163. EUROPE D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 164. EUROPE D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 165. EUROPE D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 166. EUROPE D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 167. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 168. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 169. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 170. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 171. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 172. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 173. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 174. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 175. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 176. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 177. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 178. MIDDLE EAST D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 179. AFRICA D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 180. AFRICA D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 181. AFRICA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 182. AFRICA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 183. AFRICA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 184. AFRICA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 185. AFRICA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 186. AFRICA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 187. AFRICA D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 188. AFRICA D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 189. AFRICA D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 190. AFRICA D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 191. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 192. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 193. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 194. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 195. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 196. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 197. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 198. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 199. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 200. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 201. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 202. ASIA-PACIFIC D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL D-DIMER TESTING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL D-DIMER TESTING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 205. ASEAN D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 206. ASEAN D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 207. ASEAN D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 208. ASEAN D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 209. ASEAN D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 210. ASEAN D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 211. ASEAN D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 212. ASEAN D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 213. ASEAN D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 214. ASEAN D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 215. ASEAN D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 216. ASEAN D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 217. GCC D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 218. GCC D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 219. GCC D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 220. GCC D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 221. GCC D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 222. GCC D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 223. GCC D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 224. GCC D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 225. GCC D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 226. GCC D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 227. GCC D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 228. GCC D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 229. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 230. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 231. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 232. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 233. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 234. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 235. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 236. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 237. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 238. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 239. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 240. EUROPEAN UNION D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 241. BRICS D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 242. BRICS D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 243. BRICS D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 244. BRICS D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 245. BRICS D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 246. BRICS D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 247. BRICS D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 248. BRICS D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 249. BRICS D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 250. BRICS D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 251. BRICS D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 252. BRICS D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 253. G7 D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 254. G7 D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 255. G7 D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 256. G7 D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 257. G7 D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 258. G7 D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 259. G7 D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 260. G7 D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 261. G7 D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 262. G7 D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 263. G7 D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 264. G7 D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 265. NATO D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 266. NATO D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 267. NATO D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 268. NATO D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 269. NATO D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 270. NATO D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 271. NATO D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 272. NATO D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 273. NATO D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 274. NATO D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 275. NATO D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 276. NATO D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 277. GLOBAL D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 278. GLOBAL D-DIMER TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 279. UNITED STATES D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 280. UNITED STATES D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 281. UNITED STATES D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 282. UNITED STATES D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 283. UNITED STATES D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 284. UNITED STATES D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 285. UNITED STATES D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 286. UNITED STATES D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 287. UNITED STATES D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 288. UNITED STATES D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 289. CANADA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 290. CANADA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 291. CANADA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 292. CANADA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 293. CANADA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 294. CANADA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 295. CANADA D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 296. CANADA D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 297. CANADA D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 298. CANADA D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 299. MEXICO D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 300. MEXICO D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 301. MEXICO D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 302. MEXICO D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 303. MEXICO D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 304. MEXICO D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 305. MEXICO D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 306. MEXICO D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 307. MEXICO D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 308. MEXICO D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 309. BRAZIL D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 310. BRAZIL D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 311. BRAZIL D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 312. BRAZIL D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 313. BRAZIL D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 314. BRAZIL D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 315. BRAZIL D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 316. BRAZIL D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 317. BRAZIL D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 318. BRAZIL D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 319. UNITED KINGDOM D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 320. UNITED KINGDOM D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 321. UNITED KINGDOM D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 322. UNITED KINGDOM D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 323. UNITED KINGDOM D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 324. UNITED KINGDOM D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 325. UNITED KINGDOM D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 326. UNITED KINGDOM D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 327. UNITED KINGDOM D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 328. UNITED KINGDOM D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 329. GERMANY D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 330. GERMANY D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 331. GERMANY D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 332. GERMANY D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 333. GERMANY D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 334. GERMANY D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 335. GERMANY D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 336. GERMANY D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 337. GERMANY D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 338. GERMANY D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 339. FRANCE D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 340. FRANCE D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 341. FRANCE D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 342. FRANCE D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 343. FRANCE D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 344. FRANCE D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 345. FRANCE D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 346. FRANCE D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 347. FRANCE D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 348. FRANCE D-DIMER TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 349. RUSSIA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
• TABLE 350. RUSSIA D-DIMER TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
• TABLE 351. RUSSIA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 352. RUSSIA D-DIMER TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 353. RUSSIA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 354. RUSSIA D-DIMER TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 355. RUSSIA D-DIMER TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 356. RUSSIA D-DIMER TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)

TABL